Researchers at Baylor Scott & White Research Institute have made a groundbreaking discovery in the treatment of TB.
A recent clinical study at Baylor Scott & White Health showed BCM-95 may help overcome some cases of chemotherapy resistance during pancreatic cancer treatment.
How did we treat a patient with isolated bilateral limb claudication who rapidly progressed to critical limb ischemia and required urgent surgical intervention after steroid therapy?
We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.
As an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME), we offer conferences—both live and online—at locations across our organization and the Southwest.
Our extensive network of 48 hospitals and more than 900 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.
Are current ACC/AHA guidelines too long to be effective? We discuss whether future guidelines should only include recommendations based on high-quality data that is limited to a single page that physicians can reference easier.
Sign up for an upcoming conference to help primary care providers recognize and evaluate specific pediatric subspecialty disorders seen frequently in primary care office settings.
We currently have a phase 3 study to compare LY2963016 and Lantus with mealtime insulin lispro in adult patients with type 1 diabetes mellitus with a 28-week extension and 4-week post-treatment follow-up.